Commercial-Sales & Market Access

We help clients maximize commercial value by assisting with market access, field reimbursement, prior authorization and sales.

Partnering with the top 250+ pharma, biotech and healthcare organizations

  • cardinal
  • novartis
  • abbvie
  • gilead
  • gsk
  • novo+nordisk
  • pfizer
  • roche
  • sanofi
  • takeda
  • cardinal
  • novartis
  • abbvie
  • gilead
  • gsk
  • novo+nordisk
  • pfizer
  • roche
  • sanofi
  • takeda

What we do

Our extensive experience serving pharmaceutical, biotech, medical device and diagnostic companies across all therapeutic areas has given the ACMA a deep knowledge of global commercial trends affecting the industry, including reimbursement issues such as prior authorizations to help clients maximize market access and help navigate complex healthcare issues.

aiv1 screenshot

Product launch

For product launches, we have expertise in all therapeutic areas and can help clients prepare for future launches through the ACMA Learning Library. Our strategies are customized and tailored to maximize value, with detailed market data for all major geographic regions, including emerging markets. We support both traditional pharmaceutical sales teams as well as specialty pharma sales teams with our Pharmaceutical Representative Certification (PRC) Program and Certified Specialty Pharmaceutical Professional (CSPP) Program.

Featured capabilities

We have developed sophisticated tools and solutions that can help pharmaceutical and biotech companies during the entire product development lifecycle, from discovery through post-launch. In addition, we have created digitally enabled AI solutions that help pharmaceutical companies ensure patients get the medicines they need.

reimbursement ai

Reimbursement AI

A customized, cloud based, AI solution that is trained to help healthcare professionals develop tools such as letters of medical necessity, appeals letters and generate quick answers to commonly asked questions on formulary management, reimbursement and prior authorization. This can help maximize field reimbursement team effectiveness and credibility with their external stakeholders.

pacs badge

Prior Authorization Certified Specialist (PACS™)

A holistic approach to addressing barriers to market access, the PACS program has evolved to become the go to tool for field reimbursement professionals in the pharmaceutical industry for over 5 years. This game changing resource, not only certifies your team to ensure that they understand all aspects of the reimbursement process and prior authorization obstacles, but enables them to become a valuable resource to their external stakeholders.

Overall, ACMA has the expertise and tools to support clients in all aspects of their product development and commercialization efforts, from discovery through post-launch.

ACMA Featured in the Media

yahoo news
abc news
aljazeera news
fox news
forbes news
usa today news